Profile data is unavailable for this security.
About the company
Psyence Biomedical Ltd is a Canada-based company, which develops natural psilocybin products for the healing of psychological trauma and its mental health consequences in the context of palliative care. The Company has partnered with iNGENu Pty Ltd (iNGENu) to conduct the Company’s clinical trial in palliative care. iNGENu is an Australia-based, globally focused contract research organization (CRO) with experience working in the psychedelic pharmaceutical drug development and clinical research industry. Its Phase IIb clinical trial, using PEX010, a 25mg naturally derived psilocybin drug candidate product in-licensed by the Company, in the palliative care setting.
- Revenue in USD (TTM)0.00
- Net income in USD1.52m
- Incorporated2023
- Employees--
- LocationPsyence Biomedical Ltd121 Richmond Street West PenthouseSuite 1300TORONTO M5H 2K1CanadaCAN
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| SOHM Inc | -100.00bn | -100.00bn | 1.82m | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| InVitro International | 716.89k | 6.22k | 1.82m | 16.00 | 228.57 | 2.49 | -- | 2.54 | 0.0004 | 0.0004 | 0.0402 | 0.0321 | 1.15 | -- | -- | -- | 0.995 | 7.89 | 1.09 | 8.83 | -- | -- | 0.8676 | 5.90 | -- | -- | -- | -- | -5.11 | 1.33 | -87.77 | -16.14 | -- | -- |
| PainReform Ltd | 0.00 | -17.67m | 1.89m | 6.00 | -- | -- | -- | -- | -167.66 | -167.66 | 0.00 | -14.12 | 0.00 | -- | -- | 0.00 | -309.43 | -55.47 | -650.22 | -68.20 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -6.28 | -- | -- | -- |
| Panacea Life Sciences Holdings Inc | 2.76m | -7.67m | 2.08m | 40.00 | -- | -- | -- | 0.7511 | -0.4554 | -0.4554 | 0.164 | -0.5255 | 0.1537 | 1.62 | 10.13 | 69,098.25 | -42.65 | -69.04 | -- | -225.03 | -139.49 | -181.62 | -277.51 | -505.41 | 0.0285 | -2.12 | 4.79 | -- | 46.59 | -- | 12.33 | -- | -- | -- |
| CYANOTECH CORP | 23.30m | -5.45m | 2.65m | 77.00 | -- | 0.2727 | -- | 0.1137 | -0.7939 | -0.7939 | 3.40 | 1.36 | 0.896 | 2.15 | 15.42 | 302,532.50 | -20.98 | -3.46 | -32.30 | -4.46 | 22.66 | 34.54 | -23.41 | -3.58 | 0.307 | -7.00 | 0.42 | -- | -0.4616 | -5.24 | -53.11 | -- | -6.42 | -- |
| Universe Pharmaceuticals Inc | 26.73m | -18.55m | 2.82m | 225.00 | -- | 0.0163 | -- | 0.1056 | -76.44 | -76.44 | 110.26 | 110.02 | 0.4462 | 6.13 | 1.68 | 118,781.90 | -30.97 | 5.31 | -48.85 | 7.07 | 28.27 | 46.26 | -69.40 | 6.25 | 1.46 | -0.6939 | 0.1958 | 0.00 | -19.52 | 2.53 | 29.46 | -- | -21.17 | -- |
| Scorpius Holdings Inc | 10.04m | -29.66m | 2.86m | 82.00 | -- | 0.0813 | -- | 0.2846 | -107.62 | -101.17 | 5.25 | 8.12 | 0.1725 | -- | 16.55 | 122,491.30 | -53.23 | -39.37 | -69.92 | -43.18 | 61.92 | -- | -308.58 | -1,068.21 | 0.6007 | -27.31 | 0.3146 | -- | 1,789.58 | 3.84 | 1.96 | -- | 27.32 | -- |
| Processa Pharmaceuticals Inc | 0.00 | -11.53m | 2.87m | 13.00 | -- | 0.7727 | -- | -- | -4.86 | -4.86 | 0.00 | 1.14 | 0.00 | -- | -- | 0.00 | -176.99 | -84.35 | -209.96 | -90.03 | -- | -- | -- | -- | -- | -- | 0.0022 | -- | -- | -- | 59.45 | -- | -34.05 | -- |
| Psyence Biomedical Ltd | 0.00 | 1.52m | 2.98m | -- | -- | -- | 1.97 | -- | -0.0442 | -0.0442 | 0.00 | -0.3979 | 0.00 | -- | -- | -- | 1.13 | -- | 1.20 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -2.63 | -- | -- | -- |
| Scisparc Ltd | 0.00 | -6.96m | 2.99m | 3.00 | -- | 8.40 | -- | -- | -1.22 | -1.51 | 0.00 | 0.0344 | 0.00 | -- | -- | 0.00 | -92.51 | -69.39 | -152.41 | -111.07 | -- | -- | -- | -527.17 | -- | -- | 0.9371 | -- | 113.73 | -- | -97.61 | -- | -- | -- |
| China Pharma Holdings Inc | 5.54m | -4.74m | 3.42m | 231.00 | -- | 0.5444 | -- | 0.616 | -0.3958 | -0.3958 | 0.4119 | 0.3655 | 0.3848 | 2.38 | 15.81 | 24,002.68 | -32.92 | -29.66 | -55.81 | -55.25 | -34.34 | 6.47 | -85.56 | -73.09 | 0.2605 | -27.44 | 0.377 | -- | -13.48 | -10.68 | 22.50 | -- | -25.78 | -- |
| NovaBay Pharmaceuticals Inc | 11.20m | -16.44m | 3.52m | 24.00 | -- | 3.30 | -- | 0.314 | -53.22 | -53.40 | 7.77 | 0.2195 | 1.34 | 2.22 | 13.83 | 466,625.00 | -119.49 | -61.51 | -196.48 | -83.89 | 60.67 | 59.99 | -89.25 | -86.47 | 0.9103 | -- | 0.0454 | -- | 2.24 | 3.32 | -2.66 | -- | -15.46 | -- |
| Titan Pharmaceuticals Inc | 4.00k | -5.46m | 3.59m | 4.00 | -- | 0.8998 | -- | 898.23 | -6.59 | -6.59 | 0.0049 | 4.37 | 0.0016 | -- | 0.1702 | 1,000.00 | -211.58 | -96.80 | -368.99 | -156.65 | -- | -- | -136,525.00 | -406.26 | -- | -309.96 | 0.00 | -- | -66.97 | -51.16 | 45.43 | -- | -65.61 | -- |
| Sonoma Pharmaceuticals Inc | 13.55m | -3.69m | 3.90m | 172.00 | -- | 0.7278 | -- | 0.2877 | -4.91 | -4.91 | 16.95 | 4.00 | 0.9917 | 3.11 | 5.04 | 78,761.63 | -26.98 | -29.36 | -35.49 | -40.65 | 38.52 | 38.00 | -27.21 | -30.93 | 2.84 | -- | 0.0151 | -- | -4.05 | -7.66 | 6.13 | -- | -29.84 | -- |
| Silo Pharma Inc | 72.12k | -3.71m | 4.08m | 3.00 | -- | 0.6017 | -- | 56.58 | -1.16 | -1.19 | 0.022 | 1.51 | 0.0082 | -- | -- | 24,040.00 | -42.31 | -24.90 | -46.92 | -26.39 | 91.90 | 82.79 | -5,149.53 | -2,757.85 | -- | -- | 0.00 | -- | 0.00 | -- | 7.07 | -- | -- | -- |
Data as of Nov 22 2024. Currency figures normalised to Psyence Biomedical Ltd's reporting currency: US Dollar USD
9.83%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Harraden Circle Investments LLCas of 30 Sep 2024 | 3.35m | 6.17% |
| AdvisorShares Investments LLCas of 30 Sep 2024 | 1.23m | 2.27% |
| Cantor Fitzgerald & Co.as of 30 Sep 2024 | 337.00k | 0.62% |
| Citadel Securities LLCas of 30 Sep 2024 | 169.25k | 0.31% |
| Stonehage Fleming Investment Management Ltd.as of 30 Sep 2024 | 80.50k | 0.15% |
| Morgan Stanley & Co. LLCas of 30 Sep 2024 | 48.41k | 0.09% |
| Jane Street Capital LLCas of 30 Sep 2024 | 45.96k | 0.09% |
| Tower Research Capital LLCas of 30 Sep 2024 | 34.39k | 0.06% |
| HRT Financial LP (US)as of 30 Sep 2024 | 25.77k | 0.05% |
| UBS Securities LLCas of 30 Sep 2024 | 15.03k | 0.03% |
More ▼
Data from 30 Sep 2024 - 07 Nov 2024Source: FactSet Research Systems Inc.
